Literature DB >> 23817399

Bone cement implantation syndrome.

R Razuin1, O Effat, M N Shahidan, D V Shama, M F M Miswan.   

Abstract

Bone cement implantation syndrome (BCIS) is characterized by hypoxia, hypotension, cardiac arrhythmias, increased pulmonary vascular resistance and cardiac arrest. It is a known cause of morbidity and mortality in patients undergoing cemented orthopaedic surgeries. The rarity of the condition as well as absence of a proper definition has contributed to under-reporting of cases. We report a 59-year-old woman who sustained fracture of the neck of her left femur and underwent an elective hybrid total hip replacement surgery. She collapsed during surgery and was revived only to succumb to death twelve hours later. Post mortem findings showed multiorgan disseminated microembolization of bone marrow and amorphous cement material.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817399

Source DB:  PubMed          Journal:  Malays J Pathol        ISSN: 0126-8635            Impact factor:   0.656


  4 in total

1.  Hemodynamic and Arterial Blood Gas Parameters during Cemented Hip Hemiarthroplasty in Elderly Patients.

Authors:  Mehran Soleimanha; Abbas Sedighinejad; Mohammad Haghighi; Bahram Naderi Nabi; Ahmad Reza Mirbolook; Mohsen Mardani-Kivi
Journal:  Arch Bone Jt Surg       Date:  2014-09-15

2.  Massive mass embolism detected by transesophageal echocardiography in bone cement implantation syndrome: a case report.

Authors:  Yuki Izumi; Satoshi Ishihara; Ivor Cammack; Ikuko Miyawaki
Journal:  JA Clin Rep       Date:  2019-01-24

3.  Puricelli biconvex arthroplasty as an alternative for temporomandibular joint reconstruction: description of the technique and long-term case report.

Authors:  Edela Puricelli
Journal:  Head Face Med       Date:  2022-07-29       Impact factor: 2.246

4.  The effect of intravertebral anesthesia on bone cement implantation syndrome in aged patients: A single-center 5-year retrospective study.

Authors:  Qian Chen; Chun Huang; Ya-Jun Zhang
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.